GSK to be No. 1 vaccine producer when it completes $25B asset swap with Novartis next week
February 25, 2015 at 12:58 PM EST
The $25 billion deal in which GlaxoSmithKline (NYSE: GSK) and Novartis (NYSE: NVS) will swap major assets is set to close next week, the drug companies announced Wednesday...
